Syndax Pharmaceuticals Inc
SNDX
$13.53-3.01%
End of day · as of Oct 14, 2026, 8:00 PM ET
Mkt cap
$774.43M
EV/Sales
5.71
P/E ratio
N/A
FY2025 Revenue
$172.35M
EPS (TTM)
$-2.51
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-165.60%
Beta
0.74
Div yield
N/A
Sector
Healthcare
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported SNDX revenue for 2025-12-31 was $172.4M. Net income was -$285.4M. Revenue was up 627.8% from 2024-12-31 to 2025-12-31. SNDX currently screens at market cap $774.4M.
Use this SNDX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SNDX income, balance, and cash tables.
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company in the Healthcare sector.
Latest cached Syndax Pharmaceuticals Inc (SNDX) revenue for Dec 31, 2025 was $172.4M. Net income was -$285.4M. Statements: https://lician.com/financials/sndx
Syndax Pharmaceuticals Inc (SNDX) market capitalization is $774.4M on the latest cached snapshot.
Syndax Pharmaceuticals Inc (SNDX) cached previous close $13.95; day range $13.53 – $13.92; volume 3,038,265. Session quote: https://lician.com/quote/sndx
Syndax Pharmaceuticals Inc (SNDX) latest cached earnings event is "SNDX earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SNDX filing is 8-K · Jul 14, 2026. Filings: https://lician.com/sec/sndx